Clariant taps natural sponges and apple trees for new beauty ingredients – Cosmetics Business
By daniellenierenberg
By Sarah Parsons 28-Apr-2020
Hair Care | Ingredients | Skin Care
The Swiss-led speciality chemicals manufacturer Clariant Active Ingredients has developed two new plant-based ingredients
Speciality chemicals giant Clariant has unveiled its latest beauty ingredients.
This week, the Swiss-led company launched two new plant-based ingredients for skin and hair.
Clariant Active Ingredients, Clariant's beauty business unit, released Rootness Energize, an extract of Luffa cylindrica, otherwise known as Egyptian cucumber, and can also be used as a natural cleaning sponge.
Developed for the skin, Claraint claims that sustainably-sourced Rootness Energize is rich in bryonolic acid, and can increase energy production in skin cells and stimulate ATP production.
"In turn, Rootness Energize visibly increases skin elasticity and reduces age-related lack of tonicity and firmness appealing factors for products such as firming creams, skin elasticity boosters and revitalising care products for well-aging skin care," explained the company.
Reported visible results include more than a 20% increase in firmness, tonicity and elasticity with 1% Rootness Energize.
For the hair, Clariant Active Ingredients has developed EquiScalp to target tightness, extreme dryness, itchiness and redness.
Based on stem cells from the Central Asian Malus domestica apple tree, according to the firm, the ingredient protects the scalp as it maintains the level of healthy bacteria.
Malus domestica is said to contain concentrated phloridzin, which can control inflammation as well as sebum overproduction.
Clariant Active Ingredients recommends EquiScalp for oily scalp treatments, sensitive scalp formulas and scalp itch erasers.
Alexandre Lapeyre, Global Head of Marketing, Clariant Active Ingredients, described EquiScalp and Rootness Energize as examples of using technology to develop sustainable ingredients.
"We apply science to nature to create potent actives effective at addressing very specific beauty needs, each one underpinned by plant resources preservation, traceability, no exploitation of cultural land and ecological cultivation," Lapeyre said.
"In doing so, we help cosmetic formulators support consumers requests for scientifically-proven and sustainably-sourced plant derived ingredients.
Like this story? For the latest in ingredients, formulation, packaging and regulation subscribe to SPC Magazine, for more information click here.
The rest is here:
Clariant taps natural sponges and apple trees for new beauty ingredients - Cosmetics Business
‘A key pillar of the future’: Givaudan tips growth for ingredients developed with green biotech – CosmeticsDesign-Asia.com
By daniellenierenberg
Mathais Fleury, Givaudans global category manager of biotech actives, told CosmeticsDesign-Asia that leveraging on green biotechnology would allow companies to find solutions to consumers desire for products that are natural, sustainable and high-performing.
Green Biotech truly is a key pillar of the future. Consumers are looking for more naturality while protecting nature a difficult challenge, made possible by biotech along with a high level of innovation, said Fleury.
Most recently, the Swiss company collaborated with South Korean biotech company BIO-FD&C to tackle two frustrating beauty concerns by leveraging on green biotechnology.
It recently unveiled two actives, K-phyto [SC] Camellia and K-phyto [PP] GHK, which were developed to address dry scalp and oily skin respectively.
This exclusive partnership with Bio FD&C leverages the untapped power of plants through stem cell cultures and unique phytopeptides. It allows our experts to offer innovative natural and reliable solutions for hair and skin care issues such as dry scalp and oily skin, while protecting our planet, said Fleury.
K-phyto [SC] Camellia is an ingredient obtained from camellia phytoplacenta cells culture.
According to the company, the active can increase the scalp moisture content by 13.8%. This reinforces the epidermal cohesion of the scalp keratinocytes and reduces dry flakes and dandruff down by 33.6%.
It also was observed soothe the scalp by being able to reduce erythema down 6.6%.
According to Givaudan, having botanical claims with popular ingredients such as camellia, more commonly known as Tsubaki in the region, can drive hair care product launches by 70% in APAC.
The second ingredient, K-phyto [PP] GHK, is a molecule that combines botanicals and peptides to act on the mechanisms of sebum production.
Clinical studies have shown facial sebum production reduction by 35.5% in two weeks and 67.5% in one month.
Oily skin is a major claim requested by the market, specifically in APAC. Clinical results with the phytopeptide we've chosen to bring to market are outstanding and we definitely believe this could be a game changer, said Fluery.
The Swiss firm believes that the two actives showed a lot of promise for the global market.
Our partner was already doing a very good job in its local market, but we want to leverage our access to different places over the world to highlight its expertise and know-how. This collaboration is a real opportunity to bring innovative ingredients to consumers globally, and that's why we'll offer these products to our partners all over the world, said Fleury.
Additionally, these ingredients are aligned with the ideals of clean beauty, one of the most talked-about trends in the beauty market right now.
The two technologies that we've identified in Bio FD&C portfolio are a perfect answer to this need of clean beauty combined with performance, said Fluery.
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory…
By daniellenierenberg
CRANFORD, N.J., April 27, 2020 /PRNewswire/ --Citius Pharmaceuticals, Inc.. ("Citius" or the "Company") (Nasdaq: CTXR), a specialty pharmaceutical company focused on developing and commercializing critical care drug products, today announced that it submitted a pre-IND meeting request and supporting briefing documents to the Center for Biologics Evaluation and Research ("CBER") of the FDA under the Coronavirus Treatment Acceleration Program (CTAP) on April 24. The Company has requested the Division's feedback to support the most expeditious pathway into the clinic to evaluate a novel cell therapy in patients suffering from COVID-19-related ARDS.
The cells, called NoveCite Cells or NC-MSCs, are made by Novellus, Inc. ("Novellus"), a Cambridge-based biotechnology company, using its patented mRNA-based cell-reprogramming process. NC-MSCs are mesenchymal stem cells derived from a single donor's fibroblasts that have been dedifferentiated into an induced pluripotent stem cell (iPSC) master cell bank, thereby avoiding the need to source additional donor cells. The iPSCs are then further differentiated into a mesenchymal stem cell (MSC) therapy. Citius and Novellus plan to develop NC-MSCs for the treatment of ARDS, and last month the companies signed an exclusive option agreement.
The Company plans a multi-center randomized placebo-controlled dose-finding study followed by an expansion phase to assess the safety, tolerability, and efficacy of NC-MSCs in patients with moderate to severe ARDS due to COVID-19. The proposed trial, a Phase 1b/2 clinical trial, is titled "A Randomized Placebo-Controlled Dose-Finding Study Followed by a Dose Level Expansion to Assess the Safety and Efficacy of NoveCite MSCs in Subjects with Acute Respiratory Distress Syndrome (ARDS) Due to SARS-CoV-2 Disease (COVID-19)," or "MARCO". The primary objectives of this study are to evaluate the safety and efficacy of NoveCite cells as a treatment for subjects with moderate-to-severe ARDS due to COVID-19 and to identify therapeutic doses.
"MSCs have an established track-record of clinical safety, and have shown promise in the treatment of inflammatory lung disease," said Matt Angel, PhD, co-founder and Chief Science Officer at Novellus, Inc. "Our research has shown that the NoveCite cells, being derived from mRNA-reprogrammed iPSCs, secrete higher levels of immunomodulatory proteins than donor-derived MSCs, and have unique manufacturing advantages."
"We believe we have the key elements in place from a clinical design and manufacturing point of view to evaluate this novel cell therapy approach to deal with the current pandemic," said Myron Holubiak, Chief Executive Officer of Citius. "ARDS is a very serious complication for many patients suffering from COVID-19, and is believed to account for about 80% of the deaths in ventilated patients. There is no proven or FDA-approved treatment for it, other than oxygen therapy, including use of mechanical ventilation, and fluid management. Literature from previous investigational studies with MSCs in the treatment of lung injuries support the idea that MSCs could prove effective in treating COVID-19-related ARDS. We look forward to our FDA discussions and are excited to be at the cusp of what could be a novel and effective therapy for ARDS."
About Acute Respiratory Distress Syndrome (ARDS)ARDS is a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs. ARDS is a rapidly progressive disease that occurs in critically ill patients most notably now in those diagnosed with COVID-19. ARDS affects approximately 200,000 patients per year in the U.S., exclusive of the current COVID-19 pandemic, and has a 30% to 50% mortality rate. ARDS is sometimes initially diagnosed as pneumonia or pulmonary edema (fluid in the lungs from heart disease). Symptoms of ARDS include shortness of breath, rapid breathing and heart rate, chest pain (particularly while inhaling), and bluish skin coloration. Among those who survive ARDS, a decreased quality of life is relatively common.
About Coronavirus Treatment Acceleration Program (CTAP)In response to the pandemic, the FDA has created an emergency program called the Coronavirus Treatment Acceleration Program (CTAP) to accelerate the development of treatments for COVID-19. By redeploying staff, the FDA is responding to COVID-19-related requests and reviewing protocols within 24 hours of receipt. The FDA said CTAP "uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful." In practice, that means developers of potential treatments for COVID-19 will benefit from an unusually faster track at the FDA to shorten wait times at multiple steps of the process.
About Citius Pharmaceuticals, Inc.Citius is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. For more information, please visit http://www.citiuspharma.com.
About Novellus, Inc.Novellus is a pre-clinical stage biotechnology company developing engineered cellular medicines using its non-immunogenic mRNA, nucleic-acid delivery, gene editing, and cell reprogramming technologies. Novellus is privately held and is headquartered in Cambridge, MA. For more information, please visit http://www.novellus-inc.com.
Safe HarborThis press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition, and stock price. Factors that could cause actual results to differ materially from those currently anticipated are: the risk of successfully negotiating a license agreement with Novellus within the option period; our need for substantial additional funds; the ability to access the FDA's CTAP program for the MARCO trial; the estimated markets for our product candidates, including those for ARDS, and the acceptance thereof by any market; risks associated with conducting trials for our product candidates, including those expected to be required for any treatment for ARDS and our Phase III trial for Mino-Lok; risks relating to the results of research and development activities; risks associated with developing our product candidates, including any licensed from Novellus, including that preclinical results may not be predictive of clinical results and our ability to file an IND for such candidates; uncertainties relating to preclinical and clinical testing; the early stage of products under development; risks related to our growth strategy; our ability to obtain, perform under, and maintain financing and strategic agreements and relationships; our ability to identify, acquire, close, and integrate product candidates and companies successfully and on a timely basis; our ability to attract, integrate, and retain key personnel; government regulation; patent and intellectual property matters; competition; as well as other risks described in our SEC filings. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions, or circumstances on which any such statement is based, except as required by law.
Contact:Andrew ScottVice President, Corporate Development(O) 908-967-6677 x105ascott@citiuspharma.com
SOURCE Citius Pharmaceuticals, Inc.
Continue reading here:
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory...
Stem Cell Restore Helps Regain Youthful Strength And Energy – ZOBUZ – Zobuz
By daniellenierenberg
Stem Cell Restore is a formula that works toward improving your health on a cellular level to decrease age-related weakness and fatigue. This product employs natural ingredients for reaching its goals such as resveratrol, black current cocktail, icariin, and grape seed.
Multiple research works from renowned universities back the approach that this product takes. The best part is that it makes you feel stronger, younger, more refreshed, and more energetic without requiring you to get injected with needles. A simple and convenient solution. Another anti-aging plus weight loss supplement that you can opt for is Resurge. This is a new formula by John Barban. Interested folks can learn more about Resurge customer reviews on USAToday.
Stem Cell Restore Review
Aging is the only thing in your life that is bound to happen. Unfortunately, it is not the best experience. Sure, it gives you wisdom, but those wrinkles, that weakness, declining energy levels all these negative factors completely loot the good things. After all, no one likes to wake up in the morning to feel down and weak. No one likes it when it their joints ache or when they look in the mirror to see a dull reflection.
This brings us to possible solutions that you can go for. One of these is Stem Cell Restore. This is a potent dietary supplement that has been made using natural ingredients. The product is backed by science which is what marks it as reliable. Since it comes in the form of capsules, it can be a convenient addition to your routine. Hence, if you are on the lookout for an age-reversing formula, this is one that you can invest in.
Why Choose This Product?
Around the globe, women and men alike are waiting for a magical solution for saving themselves from accelerated aging. There certainly are many options available out there. However, most of these are not worth it. Why? Because they come with negative side effects. Not to mention, these so-called techniques for erasing the effects of aging are all supremely painful. They involve countless injections or an elaborate surgery.
Would you like to still go for these youth preserving tactics? Surely, youre at the very least hesitant. If you decide to go ahead nevertheless, know that the procedures are expensive. They cost hundreds of dollars and still, they are unnatural and eventually make your skin sag. This is where Stem Cell Restore comes into the picture and steals the limelight. The dietary supplement is based on the concept of stem cell surgery.
However, it has three favorable points that win over any surgery. First of all, it doesnt cost as much. In fact, you get to become youthful, energetic, and strong all with a solution that is less than $100. Secondly, the product happens to be completely natural. It doesnt contain any harmful components such as chemicals, additives, preservatives, and the like. This translates to safe usage. Lastly, theres no needles involved; you are just supposed to take the pills regularly.
Working Of This Product
Stem Cell Restore taps into the idea of repairing cells and rejuvenating them. By doing so, it is able to refresh your health completely. All your parts from tendons and joints to your heart and kidneys are able to function better as a result. Old cells are repaired at a fast rate and new ones are created. This makes you feel fresher, and more active. Its not uncommon of people to experience bodily aches and fatigue after crossing 30 years of age.
This product is a suitable solution for everyone. It gets to the core of preserving youth and improves health. Moreover, it also tackles the issue of inflammation which is what disturbs health in numerous ways. Unlike mainstream products, your skin is not the only organ that benefits. In fact, your entire body experiences the effects. To reach its goals, the formula employs only natural ingredients which are effective at their job. As mentioned above, Resurge is another formula for deep sleep and anti-aging. It comes with a money-back guarantee. You can check out more Resurge reviews on Yahoo Finance before deciding which one to buy among the two.
Ingredients Of This Product
Stem Cell Restore has an entirely natural composition. It doesnt comprise of any such ingredients which can have damaging effects in the short- or long-run. The product is a winner mainly because of this. No additives, fillers or other such harmful components are present in the formula. Since all the ingredients are completely organic you dont have to worry about any negative side effects of use. Lets take a look at the ingredients:
Pricing Of The Product
Did you know that you can get this product for absolutely free? Yes, thats true. For a trial period, the dietary supplement is entirely free of cost. You just have to pay for shipping and handling which just requires $9.95 from your wallet. The trail period lasts for 30 days.
If the product satisfies you, its yours and automatically charges are deducted from your account or card. Thats simple and gives you a chance to see whether or not this supplement actually works. There are also three bonus products that tag along with this supplement. These come for free as well. Heres a list of the bonus product that accompany:
Verdict
Stem Cell Restore is a great product for maintaining youthful energy and strength. The product is great for recovering from the pain and fatigue that usually occurs after the age of 30. This formula repairs and encourages the production of cells through the body. In this way, it improves each organs functionality and hence, overall health. You can know more about this dietary supplement by visiting its website online.
Related
Read more from the original source:
Stem Cell Restore Helps Regain Youthful Strength And Energy - ZOBUZ - Zobuz
COVIDs devastation on the body includes the skin – Philippine Star
By daniellenierenberg
As the number of confirmed cases of COVID-19 surges past 2.5 million globally with deaths at 177,115 (as of April 22), clinicians and pathologists are struggling to understand the damage its wrought. They realize that although the lungs are ground zero, its reach can extend to many organs: Its viciousness is breathtaking and humbling.
When an infected person expels virus-laden droplets and someone else inhales them, this coronavirus enters the nose and throat. It finds a welcome home in the lining inside the nose. Cells there are rich in a surface receptor (pandikit) called angiotensin-converting enzyme 2 (ACE2), which the virus requires to enter the cell. Once inside, the virus hijacks the cells reproductive machinery, making myriad copies of itself and invading new cells.
A virus can copy anything it wants and can even make itself comfortably adapt to the environment where it chooses to stay while killing the normal cells of your body.
As it multiplies, an infected person may shed copious amounts of it, especially during the first week or so. Symptoms may be absent or the infected may develop fever, dry cough, sore throat, loss of smell and taste, or head and body aches.
Photo from dermatologyadvisor.com
If the immune system does not fight back, the virus then marches down the windpipe to attack the lungs, where it can turn deadly. This is because the thinner, distant branches of the lungs respiratory tree end in tiny air sacs called alveoli, which are also rich in ACE2 receptors. The virus can attach itself again and wreak havoc.
Normally, oxygen crosses the air sacs into the capillaries, tiny blood vessels that lie beside them. The oxygen is then carried to the rest of the body. COVID infection disrupts this healthy oxygen transfer. The front liners of our immune system, white blood cells, release inflammatory molecules called chemokines that summon more immune cells to target and kill virus-infected cells, leaving a stew of fluid and dead cells pus behind. This results in pneumonia: coughing, fever and rapid, shallow breathing.
Some COVID-19 patients recover, sometimes with no support other than oxygen. But others deteriorate, often suddenly, developing a condition called acute respiratory distress syndrome (ARDS). The oxygen levels in their blood plummet and they struggle even harder to breathe. On X-rays and computed tomography scans, their lungs are riddled with white opacities (areas without air). Commonly, these patients end up on ventilators. Many die. Autopsies show their alveoli became stuffed with fluid, white blood cells, mucus and the detritus of destroyed lung cells.
The invaders impact does not end there. The bodys response to destroy it can injure even more organs. Clinicians suspect that the driving force in many gravely ill patients downhill trajectories is a disastrous overreaction of the immune system, or cytokine storm.
Cytokines are chemical signaling molecules that guide a healthy immune response, but in a cytokine storm, levels of certain cytokines soar far beyond whats needed, and immune cells start to attack healthy tissues. Blood vessels leak, blood pressure drops, clots form and catastrophic organ failure can ensue.
Cardiovascular damage occurs.Kidneys, liver, blood vessels, the skin and brain are affected as well.Blood clots can break apart and land in the lungs, blocking vital arteries a condition known as pulmonary embolism that can kill COVID-19 patients.
Brain incursion via the nose can reach the olfactory bulb, inducing loss of smell. Clots from arteries can also lodge in the brain, causing a stroke.
Some people with COVID-19 briefly lose consciousness. Doctors wonder whether in some cases, infection depresses the brain stem reflex that senses oxygen starvation, which explains why some patients are not gasping for air, despite dangerously low blood oxygen levels.
COVID-19 can also infect the lining of the lower digestive tract, where ACE2 receptors are abundant. Viral RNA has been found in as many as 53 percent of patients stool samples, raising the unsettling possibility that it could be passed on through feces. As of this writing, theres no evidence that fecal transmission can occur.
Others develop conjunctivitis pink, watery eyes, others had elevated levels of enzymes indicating injury to the liver or bile ducts.But this may also be due to drugs or an over-driven immune system.
Lastly, cutaneous or skin manifestations have been reported in COVID-19 patients:
Generalized sporadic red rasherupting along the trunk or extremities that are typically transient and resolve on their own. They may be very itchy. Sometimes this can be confused with dengue.
Petechiae.Pinpoint bleeding underneath the skin that does not disappear when pressure is applied.
Generalized urticaria are wheal-like rashes that can coalesce together to form large plaques.
Vesicular eruptionmimicking varicella (chicken pox) blisters.
Vasculopathic presentations. Frostbite-like lesions on the feet and hands multifocal, often asymmetric patches manifest in two to three days. It then evolves to the formation of blisters, to bruises or necrosis (black, dead skin).Sometimes they appear as red, purplish bumps on the feet and hands that evolve into hemorrhagic bullae, or develop a blackish crust due to damage to the lining of the blood vessels, leading to clots that block blood vessels. These can lead to ulcer or gangrene formation, and death.
Acute hemorrhagic edema in infants.Sudden swelling of limbs with patches of bruises in a well-appearing child, before the rash dissipates in 48 hours along with the swelling.
Erythematouslarge patches scattered all over the body that may be slightly itchy.
Localized extreme pruritus,like in the wrist or ankle areas only.
This map of the devastation that COVID-19 can inflict on the body is still just a sketch. It will take years of painstaking research to sharpen the picture of its reach.
* * *
For inquiries, call 8401-8411 or 0917-497-6261, 0999-883-4802 or email gc_beltran@yahoo.com. Follow me on facebook@dragracebeltran.
Continued here:
COVIDs devastation on the body includes the skin - Philippine Star
Cosmetic Skin Care Market to see impressive Growth by 2027| Leading Companies- L’Oral, Unilever, Espa, Kao, Johnson & Johnson – Cole of Duty
By daniellenierenberg
Cosmetic Skin CareMarketBusiness Insights and Updates:
The latest Marketreport by a Data Bridge Market Researchwith the title[Global Cosmetic Skin CareMarket Industry Trends and Forecast to 2026].The new report on the worldwide Cosmetic Skin CareMarketis committed to fulfilling the necessities of the clients by giving them thorough insights into the Market. The various providers involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.The reports provide Insightful information to the clients enhancing their basic leadership capacity identified.Exclusive information offered in this report is collected by analysis and trade consultants.
Global cosmetic skin care market is set to witness a substantial CAGR of 5.5% in the forecast period of 2019- 2026.
Cosmetic skin care is a variety of products which are used to improve the skins appearance and alleviate skin conditions. It consists different products such as anti- aging cosmetic products, sensitive skin care products, anti- scar solution products, warts removal products, infant skin care products and other. They contain various ingredients which are beneficial for the skin such as phytochemicals, vitamins, essential oils, and other. Their main function is to make the skin healthy and repair the skin damages.Get PDF Samplecopy(including TOC, Tables, and Figures) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cosmetic-skin-care-market
Thestudy considers the Cosmetic Skin CareMarketvalue and volume generated from the sales of the following segments:Major Marketmanufacturerscovered in the Cosmetic Skin CareMarketare:LOral, Unilever, New Avon Company, Este Lauder Companies, Espa, Kao Corporation, Johnson & Johnson Services, Inc., Procter & Gamble, Beiersdorf, THE BODY SHOP INTERNATIONAL LIMITED, Shiseido Co.,Ltd., Coty Inc., Bo International, A One Cosmetics Products, Lancme, Clinique Laboratories, llc., Galderma Laboratories, L.P., AVON Beauty Products India Pvt Ltd, Nutriglow Cosmetics Pvt. Ltd, Shree Cosmetics Ltd
By Product
By Application
By Gender
By Distribution Channel
Get Table of Contents with Charts, Figures & Tables @https://www.databridgemarketresearch.com/toc/?dbmr=global-cosmetic-skin-care-market
Based on regions, the Cosmetic Skin CareMarketis classified into North America, Europe, Asia- Pacific, Middle East & Africa, and Latin AmericaMiddle East and Africa (GCC Countries and Egypt)North America (United States, Mexico, and Canada)South America(Brazil, Argentina etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)
Market Drivers:
Market Restraints:
Key Developments in the Market:
Key Benefits for Cosmetic Skin CareMarket:
Enquire Here For Discount Or Cosmetic Skin CareMarket Report Customization@https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cosmetic-skin-care-market
About Us:Data Bridge Marketresearch endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process Data Bridge set forth itself as an unconventional and neoteric Marketresearch and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Marketopportunities and foster efficient information for your business to thrive in the Market.We ponder into the heterogeneous Markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the Markettrends. Data Bridge delves into the Markets across Asia, North America, South America, Africa to name few.
Contact Us:Data Bridge MarketResearchUS: +1-888-387-2818
Read the original here:
Cosmetic Skin Care Market to see impressive Growth by 2027| Leading Companies- L'Oral, Unilever, Espa, Kao, Johnson & Johnson - Cole of Duty
New type of immune cell discovered in breast ducts – Mirage News
By daniellenierenberg
(L-R) Professor Geoff Lindeman and Professor Jane Visvader
are joint heads of the Institutes ACRF Stem Cells and Cancer
Division.
Using advanced three-dimensional (3D) imaging techniques, the team observed how the immune cells monitor for threats in the mammary ducts and help to maintain tissue health by eating up dying milk-producing cells needing to be cleared away once lactation stops.
The preclinical research was led by Walter and Eliza Hall Institute researchers Dr Caleb Dawson, Professor Geoff Lindeman and Professor Jane Visvader, along with Dr Anne Rios who is now based at the Princess Mxima Center for Pediatric Oncology, Netherlands. It was published today in the journal Nature Cell Biology.
Institute breast cancer researcher Dr Caleb Dawson.
The mammary gland is a dynamic organ that undergoes dramatic remodelling throughout life. The branching ducts bloom to form milk-producing factories in lactation, which must be eliminated once lactation stops. Mammary ducts are of particular interest to breast cancer researchers because this site is prone to cancer development.
While exploring mammary ducts using high-resolution imaging techniques, Dr Dawson said the researchers were surprised to discover a new immune cell type, and its specific role in maintaining healthy, intact breast tissue.
We discovered an entirely new population of specialised immune cells, which we named ductal macrophages, squeezed in between two layers of the mammary duct wall.
We were excited to find that these cells play an essential role at a pivotal point in mammary gland function called involution when lactation stops, milk-producing cells die and breast tissue needs to remodel back to its original state, he said.
We watched incredulously as the star-shaped ductal macrophages probed with their arms and ate away at dying cells. The clearing action performed by ductal macrophages helps redundant milk-producing structures to collapse, allowing them to successfully return to a resting state, Dr Dawson said.
When the researchers later removed ductal macrophages from the mammary ducts they discovered that no other immune cells were able to swiftly carry out this essential process.
Most organs in the body including the brain, liver, lung, skin and intestine have their own population of macrophages a name of Greek origin that means big eater. These cells play important roles in regulating infection, inflammation and organ function within their sites of residence.
Professor Visvader said discovering mammary duct-specific macrophages was a remarkable step forward in understanding how the immune system interacted with the ductal network and impacted upon mammary gland development.
As breast cancer researchers, there is a need to understand which cells are doing what, so that we can identify how these intricate cellular processes become dysregulated, such as in the case of breast cancers, she said.
More than 19,000 Australians are diagnosed with breast cancer every year. It is the most common cancer in Australian women.
Dr Dawson said that going forward, the team hoped to explore the function of ductal macrophages at different stages of mammary gland development, such as the transitions into adulthood and pregnancy.
We also want investigate the role that these duct-specific immune cells play in helping cancer to grow and spread.
Ductal macrophages are spread throughout the mammary ducts. As cancer grows, these macrophages also increase in number. We suspect that theres the potential for ductal macrophages to inadvertently dampen the bodys immune response, which would have dangerous implications for the growth and spread of cancer in these already prone sites, Dr Dawson said.
Professor Visvader said the teams ultimate goal was to understand these cells enough to manipulate them.
Given that tumour macrophages likely promote growth of the tumour, blocking their activity could serve as a treatment strategy for breast cancer, she said.
The research was supported by the National Health and Medical Research Council, the National Breast Cancer Foundation, the Australian Cancer Research Foundation, The Qualtrough Cancer Research Fund, Cure Cancer Australia and the Victorian Government.
Read more:
New type of immune cell discovered in breast ducts - Mirage News
Sustainably Yours: The importance of understanding and trusting in Science – The Phuket News
By daniellenierenberg
In his book 21 Lessons for The 21st Century, historian Yuval Noah Harari begins by writing, In a world deluged by irrelevant information, clarity is power. Before the Internet, access to information was relatively limited, and media was concentrated in the hands of a few corporations, which had its problems.
When it comes to supposed facts about COVID-19 posted on the internet, its best to check first with those doing the real checking: scientists. Photo: AFP
Today, with YouTubers, bloggers, and social media at our fingertips, the world is filled with more information than ever. The problem is that much of it is fake news and rumours. Too many voices are clamouring for our attention, but few are fact-checked for accuracy.
Since the spread of COVID-19 began, weve seen snake oil salesmen hawking cures and prophylaxis, and the spread of conspiracy theories about the viruss origins.
In a world where breathing the same air as someone else can kill you, misinformation can be as deadly as the virus. Now more than ever we need to be mindful of what we say, what we post, and how we behave. So, we need to understand and trust in science.
Why Should We Believe in Science?
According to Harvard Professor Naomi Oreskes, author of Why Trust Science?, for several decades there has been an organised campaign to undermine the publics trust in science funded mainly by industries whose financial interests are threatened by its findings.
At its core, science is the study of how the natural world works.
It has a long history of success, and when done correctly it is the single best method of inquiry we have for the pursuit of truth. Because of science, we have aeroplanes, cars, GPS, the Internet, smartphones and modern medicine. The only reason we know that COVID-19 exists is because of science. More importantly, science is a self-policing system of checks and balances that exists to reveal problems and correct inaccuracies.
It begins with the scientific method, something we all learned in school:
Once a scientist has drawn a conclusion, it undergoes rigorous scrutiny by colleagues who are working in the same discipline. This process of scrutiny can lead to rejecting or accepting the hypothesis, redesigning the experiment or finding additional data to support the conclusion. If the claim is valid, the scientist then publishes their work in a reputable scientific journal such as Nature or Science.
Submission of a paper begins the rigorous peer-review process where experts in the same field deliberately challenge the scientists arguments, inspect their data and look for errors in their methodology. So, before a claim is made and the general media gets a hold of it, a study is peer-reviewed and subjected to scrutiny by dozens, if not hundreds of other experts in the same field.
In areas where there is a scientific consensus, such as the relative safety and efficacy of vaccines, or that climate change is anthropogenic, thousands of studies on these topics have been published over decades and reviewed by thousands of scientists in dozens of countries.
Professor Oreskes notes that a critical aspect of scientific judgment is that it is done collectively and not individually. This weeds out personal biases or someone who might have a specific agenda.
Scientific claims are put through a process much like a trial. Questions are posed, data is analysed, and facts are debated before the community comes to a consensus. This process can take years, even decades. So, when your beliefs are founded on scientific consensus, you are relying on the knowledge of dozens if not hundreds, or thousands of experts in their fields.
Because COVID-19 is still so new, there are lots of unknowns. It will take time to review the data and draw definitive conclusions. There remains speculation about how the virus transmits, whether recovered patients acquire sustained immunity, the effect of heat and humidity have on infection rates and the viability of various treatments, among other things. Nevertheless, our reaction to COVID-19 should be grounded in facts, evidence and empirical data rather than, unfounded opinions, suppositions and fears.
Science Makes Mistakes
Like any other human discipline, science has its failures. For example, in 2014, Japanese biologist Haruko Obokata knowingly falsified data regarding the creation of stimulus acquired pluripotent (STAP) cells in mice. If her claim had been valid, it would have revolutionised the production of embryonic stem cells, which are blank cells that can be programmed to become any of 200 different cell types in the human body, including bone, hair, skin or muscle.
However, due to the self-policing nature of science, within days, other biologists in her field refuted her claims after failing to replicate her experiments. Within months, her paper was retracted, and her career ended in disgrace.
Knowing that science sometimes makes mistakes and admits and corrects for them shouldnt make us trust it any less if anything it should make us believe in it more. Especially when compared to other methods of inquiry, which have no process of scrutiny.
The Problem with Intuition
In his book Thinking Fast Thinking Slow, Nobel Prize-winning behavioural economist Daniel Kahneman defined intuition as, Thinking that you know something without knowing why you do. As an example, he poses this problem:
A bat and ball cost $1.10.
The bat costs one dollar more than the ball.
How much does the ball cost?
If you answered 10 cents, you are incorrect. This question confounds 50% of students from some of the best universities in the world.
The correct answer is 5 cents.
Kahneman identifies two methods for problem-solving. System 1 is quick, intuitive, spontaneous and effortless. It instantly helps us to recognise faces, to act when confronted with dangers and to solve simple questions. System 2 is slow, rational, reflective and effortful. It gets into the drivers seat when you focus and concentrate on a complicated problem.
The problems occur when we try to use System 1 to make complex decisions that require System 2. People will often make judgements based on intuition when a given situation is easy to imagine. For example, when asked what the most dangerous method of generating energy is, public opinion is usually most negative toward nuclear. However, on a per terawatt-hour basis, atomic energy has killed far fewer people than oil, coal and even solar. But because most people conflate nuclear power with war, they tend to answer incorrectly.
When our perception of reality is based on stories that people tell us, rather than science, facts and evidence, it leads to poor decisions. In the modern world, we need to learn to think in terms of data as it is a far too complicated a place to always reason by intuition.
Linear Vs. Exponential Thinking
Part of the reason many governments didnt foresee the problems COVID-19 would create is that their leaders are linear thinkers.
As an example, if you take 30 linear steps, you move 30 standard paces from where you started, or about 30 metres. However, if you take 30 exponential steps, one, two, four, eight, sixteen by the time you get to the last step, you end up a billion metres from where your started thats about 26 times around the planet!
Its the reason why at the beginning of March the United States only had 65 infections and by April 14 it had over 500,000.
We are In This Together
Whether we like it or not, we are in this together. The virus doesnt distinguish between race, social class, tourist, expat or Thai.
We must be careful about what we say or post in social media. The virus kills quickly, but misinformation can also kill by influencing people to do foolish things.
For sources of science that have been peer-reviewed or vetted by experts, you can go to the following websites:
PubMed
The Lancet
Nature Medicine
The New England Journal Of Medicine
The British Medical Journal
WebMD
Healthline
When we depend on intuition, gossip, fake news and conspiracy theories to make decisions, we get leaders who make demonstrably poor decisions that lead to disastrous consequences. In this regard many people think of Donald Trump.
To quote John F. Kennedy, We are not here to curse the darkness, but to light the candle that can guide us through that darkness to a safe and sane future.
Science, both literally and figuratively, is that light; to disregard it is to remain in the dark.
See the article here:
Sustainably Yours: The importance of understanding and trusting in Science - The Phuket News
Repurpose your sleep masks to keep WFH skin fresh and hydrated all day – Well+Good
By daniellenierenberg
Whether youre blasting the heat or AC (or both, because, April), staying inside all day puts you on the fast track to dry skin. Unless youve got a humidifier decorating your WFH space, the air in your home is ripe for sucking the moisture straight out of your face. And while diligently slathering on moisturizer every hour on the hour is certainly one way to hold in the hydration, the easiest method to hydrate skin at home is actually by repurposing your hydrating sleep mask for use during waking hours.
No, were not talking sleeping eye masks. Think of sleep masks, which came to us by way of K-beauty and popularized over the last few years, as a sort of jacket for your skin. Unlike regular masks, they dont need to be washed off, and they create a protective boundary between your skin and environment thats even tougher to permeate than your usual skin products. We recommend using a concentrated mask during the day when working from home, because your skin is so susceptible to losing moisture if you dont adequately hydrate it, says Glow Recipe founder Sarah Lee. Because overnight masks are usually very hydrating with nourishing properties, it really helps to keep that moisture retained throughout the hours. Because of this, its also a great way to maximize the ingredients youre getting from the products youre applying underneath it.
A sleep mask should be the final layer after your usual skin-care routine, and can go on either on top of your moisturizer or in place of it. Scroll through for our favorite picks worth dedicating a spot to in your routine.
This influencer-approved mask is chock full of vitamins (C and E, to be specific) and amino acids that give dull, sleepy skin an instant boost. Its got antioxidants to help protect from free-radical damage, and ceramides to really lock in the moisture it provides.
A combination of watermelon and hyaluronic acid helps to infuse moisture in the skin, and a mixture of AHAs (including glycloic and lactic acids) clear away the top layer of dead skin cells to help moisture penetrate more deeply. The jelly texture is ultra light so that you wont feel like youve got some goopy mask on your face all day long, and can you beat the packaging?
This drugstore beauty buy is not only immensely hydrating (and under $20), but it also leaves behind a pearlescent finish that will make you look luminous while you work. Its formulated with skin-soothing niacinamide and moisture-drawing humectants to hydrate and brighten as it absorbs.
Thanks to its barely-there, water-based formula, this jelly mask absorbs almost immediately into your skin. In addition to highly concentrated mineral water, its also packed with calming and brightening ingredients like orange flower, rose, sandalwood, apricot, and evening primrose. Thirsty pores will drink it right up.
With this mask, youll be waking up, spending your day,and going to sleep beautiful. Its got all kinds of nourishing, natural ingredients like quinoa, mushrooms, and floral stem cells, and is infused with aromatherapy elements to help keep you calm throughout the work day.
Originally posted here:
Repurpose your sleep masks to keep WFH skin fresh and hydrated all day - Well+Good
Reversing diabetes with CRISPR and patient-derived stem cells – FierceBiotech
By daniellenierenberg
Insulin injections cancontrol diabetes, but patients still experience serious complications such as kidney disease and skin infections. Transplanting pancreatic tissues containing functional insulin-producing beta cells is of limited use, because donors are scarce and patients must take immunosuppressant drugs afterward.
Now, scientists atWashington University in St. Louis havedeveloped a way to use gene editing system CRISPR-Cas9 to edit a mutation in human-induced pluripotent stem cells (iPSCs) and then turnthem into beta cells. When transplanted into mice, the cells reversed preexisting diabetes in a lasting way, according to results published in the journal Science Translational Medicine.
While the researchers used cells from patients with Wolfram syndromea rare childhood diabetes caused by mutations in the WFS1 genethey argue that the combination of a gene therapy with stem cells could potentially treat other forms of diabetes as well.
Virtual Clinical Trials Online
This virtual event will bring together industry experts to discuss the increasing pace of pharmaceutical innovation, the need to maintain data quality and integrity as new technologies are implemented and understand regulatory challenges to ensure compliance.
One of the biggest challenges we faced was differentiating our patient cells into beta cells. Previous approaches do not allow for this robust differentiation. We use our new differentiation protocol targeting different development and signaling pathways to generate our cells, the studys lead author, Kristina Maxwell, explained in a video statement.
Making pancreatic beta cells from patient-derived stem cells requires precise activation and repression of specific pathways, and atthe right times, to guide the development process. In a recent Nature Biotechnology study, the team described a successful method that leverages the link between a complex known as actin cytoskeleton and the expression of transcription factors that drive pancreatic cell differentiation.
This time, the researchers applied the technology to iPSCs from two patients with Wolfram syndrome. They used CRISPR to correct the mutated WFS1 gene in the cells and differentiated the edited iPSCs into fully functional beta cells.
After transplanting the corrected beta cells into diabetic mice, the animals saw their blood glucose drop quickly, suggesting the disease had been reversed. The effect lasted for the entire six-month observation period, the scientists reported. By comparison, those receiving unedited cells from patients were unable to achieve glycemic control.
RELATED:CRISPR Therapeutics, ViaCyte team up on gene-edited diabetes treatment
The idea of editing stem cells with CRISPR has already attracted interest in the biopharma industry. Back in 2018, CRISPR Therapeutics penned a deal with ViaCyte to develop off-the-shelf, gene-editing stem cell therapies for diabetes. Rather than editing iPSCs from particular patients themselves to correct a faulty gene, the pairs lead project used CRISPR to edit healthy cells so that they lackedthe B2M gene and expressed PD-L1 to protect against immune attack. The two companies unveiled positive preclinical data inSeptember.
Other research groups working on gene therapy or stem cells for diabetes include a Harvard University scientist and his startup Semma Therapeutics, whichdeveloped a method for selecting beta cells out of a mixture of cells developed from PSCs. Scientists at the University of Wisconsin-Madison recently proposed that removing the IRE1-alpha gene in beta cells could prevent immune T cells from attacking them in mice with Type 1 diabetes.
The Washington University team hopes its technology may help Type 1 diabetes patients whose disease is caused by multiple genetic and environmental factors as well as the Type 2 form linked to obesity and insulin resistance.
We can generate a virtually unlimited number of beta cells from patients with diabetes to test and discover new drugs to hopefully stop or even reverse this disease, Jeffrey Millman, the studys co-senior author, said in the video statement. Perhaps most importantly, this technology now allows for the potential use of gene therapy in combination with the patients own cells to treat their own diabetes by transplantation of lab-grown beta cells.
Here is the original post:
Reversing diabetes with CRISPR and patient-derived stem cells - FierceBiotech
Potential Impact of COVID-19 on Cosmetic Skin Care Market to Show Outstanding Growth by 2025 Profiling Global Players Industry Developments, Outlook,…
By daniellenierenberg
The global Cosmetic Skin Care market reached ~US$ xx Mn in 2019and is anticipated grow at a CAGR of xx% over the forecast period 2019-2029. In this Cosmetic Skin Care market study, the following years are considered to predict the market footprint:
The business intelligence study of the Cosmetic Skin Care market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the Cosmetic Skin Care market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the Cosmetic Skin Care market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the Global region.
Request Sample Report @https://www.mrrse.com/sample/6559?source=atm
below:
Global Cosmetic Skin Care Market, Product Analysis
Global Cosmetic Skin Care Market, Application Analysis
In addition the report provides cross-sectional analysis of all the above segments with respect to the following geographical markets:
Global Cosmetic Skin Care Market, by Geography
Each market player encompassed in the Cosmetic Skin Care market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the Cosmetic Skin Care market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.
COVID-19 Impact on Cosmetic Skin Care Market
Adapting to the recent novel COVID-19 pandemic, the impact of the COVID-19 pandemic on the global Cosmetic Skin Care market is included in the present report. The influence of the novel coronavirus pandemic on the growth of the Cosmetic Skin Care market is analyzed and depicted in the report.
Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/6559?source=atm
What insights readers can gather from the Cosmetic Skin Care market report?
The Cosmetic Skin Care market report answers the following queries:
Buy This Report @ https://www.mrrse.com/checkout/6559?source=atm
Why Choose Cosmetic Skin Care Market Report?
Breakouts: Why is my skin worse during the coronavirus pandemic? – Express
By daniellenierenberg
The coronavirus crisis is affecting every aspect of our lives, including the condition of our skin. Have you noticed that your skin is particularly spotty, irritated and angry lately? That's another thing you can blame on COVID-19.
Express.co.ukspoke to Dr. Luca Russo, Dermatologist at Urban Retreat, to find out why.Dr. Russo says there are several reasons for your unexpected breakouts.He said: "There might be several reasons for noticing a tendency to break out during this national emergency."It's probably to do with what's going on inside, and what you're putting in your body, says Dr. Russo.
READ MORE- Coronavirus symptoms: Man reveals skin-related warning sign
Are you up all night worrying about the virus?Dr. Russo says: "The most likely cause of your breakout is stress."During such uncertain and stressful times, our system copes with increased production of Cortisol."Cortisol is an androgen hormone that is released when we are facing unusual challenges and prepare us to "fight'."However, it will also increase the sugar level in the bloodstream and production of sebum that might be a cause of the breakout."
In order to prevent breakouts that stem from high levels of stress, you'll need to calm yourself down.Dr Russo recommends doing activities that allow you to relax and unwind, such as yoga.He also suggests exercising regularly, so it's time to start making use of that daily government-approved walk, cycle, or run.
If you hate exercising, don't worry, the antidote to high cortisol levels doesn't have to be physical.Laughing, a solid night of sleep, or practising your favourite hobby are all effective options.
Having a soak in the bath and doing a face-mask may help you feel more in control of your skin.
This relief may cause a decrease in oil production and pimples.
DON'T MISS...How to help your brain through the coronavirus crisis stress [EXPLAINER]Coronavirus: How to look after your mental health during lockdown [EXPLAINER]Lockdown exercise: The eight exercises you can do at home [INFORMER]
Can you honestly say you have been eating well throughout the lockdown?Most people have stocked up on sugary treats and salty snacks in order to cheer themselves up in the face of COVID-19.And what about the good-old "support local businesses" excuse you use every time you order a greasy takeaway?Dr Russo says: "During isolation food becomes one of the few focal points of the day with more consumption of comfort food."Just like any other organ in your body, a poor diet affects your skin negatively.The body breaks down our food into tiny particles of proteins, fats, and carbs, and circulates it to the organs that need them.These nutrients make their way to your skin too, impacting its condition.It makes sense that inflammatory foods, such as sweets, some dairy, processed meat, and refined carbohydrates, will cause a flare-up in your complexion.
Dr. Russo says: "To improve your skin, you must eat well."Eat foods that are packed with vitamins and proteins and snack on fruit and veg."Drinking lots of water will replace the moisture that is lost through sweat and other processes, keeping your skin hydrated.If you fill up on foods rich in healthy oils and omega-3 fatty acids, you will improve the collagen production in your skin.This makes your skin smoother, suppler, and will help you in the longterm by preventing premature ageing.These oils and fats are found in fish, nuts, olive oil, and many more commonly found items.
During the lockdown, we're stuck inside all day and often don't get a chance to let our skin feel the sun.Dr. Russo says: "At the moment, skin isn't being exposed to natural light much at all."When your skin is exposed to natural light, the production of Vitamin D is increased."Endorphins are also produced, and this boosts your immune system and well-being."Make sure you get some fresh air every day, in order to reap these benefits of the sun.The sun is a great natural resource to improve your skin, but make sure you protect yourself with sun protection before you go out.You should wear an SPF of at least 30 on your face whenever you leave the house or are in front of a window for a prolonged amount of time.
Most people are shunning makeup in favour of the natural look since no one other than our household is going to see our faces.This means you may be tempted to skip your cleansing routine and go straight to bed once the day is over.
If you normally get facials and now can't, this may also be why you are breaking out or seeing changes.Dr. Russo explains: "You have probably been unable to receive professional treatments over this time, and this will contribute towards your breakouts."Dr. Russo recommends continuing with your normal skincare routine.He says: "Carry on as normal, but add an exfoliating cleanser to your routine."Exfoliating cleansers make your skincare routine shorter, by combining exfoliating and cleansing in one step.They remove dead skin cells and any build-up of dirt and oil in one go.There are hundreds of physical exfoliating cleansers on the market, as well as chemical exfoliating cleansers, so take your pick!
While surgical masks are thought to protect us against coronavirus, they're not great for our skin, said Dr. Russo.Wearing a mask over your face for many hours is damaging to your skin, especially when it's hot outside.The mask offers the perfect spot for bacteria and germs to harbour.Try double cleansing on the lower half of your face if you've worn a surgical mask for a prolonged period of time.
The rest is here:
Breakouts: Why is my skin worse during the coronavirus pandemic? - Express
Researchers use cell therapy to recover damaged brain areas in mice that suffered – Mirage News
By daniellenierenberg
Dispositiu per a realitzar registres electrofisiolgics amb les llums LED incorporades per lus doptogentica.
Equip investigador.
Researchers from Lund University (Sweeden) and the Institute of Neurosciences of the University of Barcelona (UBNeuro) have recovered, through cell therapy, the mobility and sensibility of mice that suffered a cardiovascular accident. The results of this study were published in the journal Proceedings of the National Academy of Sciences (PNAS).
Researchers used an ischemic model of ictus in mice to which they transferred stem cells obtained from the skin of a healthy human donor. The cells were reprogramed to become neuronal progenitors of the damaged area of the brain, specifically the brain cortex. Six months after the transplant, researchers could observe how the new cells had repaired the damage that was caused by the cerebrovascular injury. In addition, the sensor and motor problems resulting from the stroke had been reversed as well.
We observed that the fibers of the cells that were put in the cortical area grew and created connections in brain areas that are far from the transplant area, notes Daniel Tornero, researcher in the Laboratory of Stem Cells and Regenerative Medicine in UBNeuro. To identify the transplanted cells, researches used different techniques that enable the monitoring so as to prove the connection in damaged circuits is right. Although there is a lot of work to do -the researcher adds-, the study sheds light on the possibility of replacing the damaged cells for new healthy cells in patients with ictus.
This is the last study of a series of three articles in which the researchers used cell therapy to work on brain healing. Previous studies showed it is possible to transplant nervous cells derived from human stem cells or reprogrammed cells in the brain of mice affected by cardiovascular injuries. However, researchers did not know whether the transformed cells could create new connections in the mice brains and restore the movement and feelings of touch.
The next step is to understand how the transplant affects intellectual functions such as memory, and the potential adverse effects, concludes Tornero.
Article reference:
S. Palma-Tortosa, D. l Tornero, M. Grnning Hansen, E. Monni, M. Hajy, S. Kartsivadze, S. Aktay, O. Tsupykov, M. Parmar, K. Deisseroth, G. Skibo, O. Lindvall, y Z. Kokaia. Activity in grafted human iPS cellderived corticalneurons integrated in stroke-injured rat brain regulatesmotor behavior. Proceedings of the National Academy of Sciences (PNAS). Doi: doi: 10.1073/pnas.2000690117
The rest is here:
Researchers use cell therapy to recover damaged brain areas in mice that suffered - Mirage News
Diabetes Reversed in Mice With CRISPR-Edited Stem Cells From Patients – Technology Networks
By daniellenierenberg
Using induced pluripotent stem cells produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes calledWolfram syndrome, researchers transformed the human stem cells into insulin-producing cells and used the gene-editing tool CRISPR-Cas9 to correct a genetic defect that had caused the syndrome. They then implanted the cells into lab mice and cured the unrelenting diabetes in those mice.
The findings, from researchers at Washington University School of Medicine in St. Louis, suggest the CRISPR-Cas9 technique may hold promise as a treatment for diabetes, particularly the forms caused by a single gene mutation, and it also may be useful one day in some patients with the more common forms of diabetes, such as type 1 and type 2.
The study is published online April 22 in the journal Science Translational Medicine.
Patients with Wolfram syndrome develop diabetes during childhood or adolescence and quickly require insulin-replacement therapy, requiring insulin injections multiple times each day. Most go on to develop problems with vision and balance, as well as other issues, and in many patients, the syndrome contributes to an early death.
This is the first time CRISPR has been used to fix a patients diabetes-causing genetic defect and successfully reverse diabetes, said co-senior investigatorJeffrey R. Millman, PhD, an assistant professor of medicine and of biomedical engineering at Washington University. For this study, we used cells from a patient with Wolfram syndrome because, conceptually, we knew it would be easier to correct a defect caused by a single gene. But we see this as a stepping stone toward applying gene therapy to a broader population of patients with diabetes.
Wolfram syndrome is caused by mutations to a single gene, providing the researchers an opportunity to determine whether combining stem cell technology with CRISPR to correct the genetic error also might correct the diabetes caused by the mutation.
A few years ago, Millman and his colleagues discovered how to convert human stem cells into pancreatic beta cells. When such cells encounter blood sugar, they secrete insulin. Recently, those same researchers developed a new technique to more efficiently convert human stem cells into beta cells that are considerably better at controlling blood sugar.
In this study, they took the additional steps of deriving these cells from patients and using the CRISPR-Cas9 gene-editing tool on those cells to correct a mutation to the gene that causes Wolfram syndrome (WFS1). Then, the researchers compared the gene-edited cells to insulin-secreting beta cells from the same batch of stem cells that had not undergone editing with CRISPR.
In the test tube and in mice with a severe form of diabetes, the newly grown beta cells that were edited with CRISPR more efficiently secreted insulin in response to glucose. Diabetes disappeared quickly in mice with the CRISPR-edited cells implanted beneath the skin, and the animals blood sugar levels remained in normal range for the entire six months they were monitored. Animals receiving unedited beta cells remained diabetic. Their newly implanted beta cells could produce insulin, just not enough to reverse their diabetes.
We basically were able to use these cells to cure the problem, making normal beta cells by correcting this mutation, said co-senior investigatorFumihiko Urano, MD, PhD, the Samuel E. Schechter Professor of Medicine and a professor of pathology and immunology. Its a proof of concept demonstrating that correcting gene defects that cause or contribute to diabetes in this case, in the Wolfram syndrome gene we can make beta cells that more effectively control blood sugar. Its also possible that by correcting the genetic defects in these cells, we may correct other problems Wolfram syndrome patients experience, such as visual impairment and neurodegeneration.
In the future, using CRISPR to correct certain mutations in beta cells may help patients whose diabetes is the result of multiple genetic and environmental factors, such as type 1, caused by an autoimmune process that destroys beta cells, and type 2, which is closely linked to obesity and a systemic process called insulin resistance.
Were excited about the fact that we were able to combine these two technologies growing beta cells from induced pluripotent stem cells and using CRISPR to correct genetic defects, Millman said. In fact, we found that corrected beta cells were indistinguishable from beta cells made from the stem cells of healthy people without diabetes.
Moving forward, the process of making beta cells from stem cells should get easier, the researchers said. For example, the scientists have developed less intrusive methods, making induced pluripotent stem cells from blood and they are working on developing stem cells from urine samples.
In the future, Urano said, we may be able to take a few milliliters of urine from a patient, make stem cells that we then can grow into beta cells, correct mutations in those cells with CRISPR, transplant them back into the patient, and cure their diabetes in our clinic. Genetic testing in patients with diabetes will guide us to identify genes that should be corrected, which will lead to a personalized regenerative gene therapy.
Reference:
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.
See the original post here:
Diabetes Reversed in Mice With CRISPR-Edited Stem Cells From Patients - Technology Networks
Induced pluripotent stem cells and CRISPR reversed diabetes in mice – Drug Target Review
By daniellenierenberg
Induced pluripotent stem cells made to produce insulin and CRISPR, used to correct a genetic defect, cured Wolfram syndrome in mice.
Using induced pluripotent stem cells (iPSCs) produced from the skin of a patient with a rare, genetic form of insulin-dependent diabetes called Wolfram syndrome, researchers transformed the human stem cells into insulin-producing cells and used CRISPR-Cas9 to correct a genetic defect that had caused the syndrome. They then implanted the cells into lab mice and cured the unrelenting diabetes in those models.
The findings, from researchers at Washington University School of Medicine in St. Louis, US, suggest this CRISPR-Cas9 technique may hold promise as a treatment for diabetes, particularly the forms caused by a single gene mutation and it also may be useful one day in some patients with the more common forms of diabetes, such as type 1 and type 2.
This is the first time CRISPR has been used to fix a patients diabetes-causing genetic defect and successfully reverse diabetes, said co-senior investigator Dr Jeffrey Millman, an assistant professor of medicine and of biomedical engineering at Washington University. For this study, we used cells from a patient with Wolfram syndrome because, conceptually, we knew it would be easier to correct a defect caused by a single gene. But we see this as a stepping stone toward applying gene therapy to a broader population of patients with diabetes.
Wolfram syndrome is caused by mutations to a single gene, providing the researchers an opportunity to determine whether combining stem cell technology with CRISPR to correct the genetic error also might correct the diabetes caused by the mutation.
Researchers at Washington University School of Medicine in St. Louis have transformed stem cells into insulin-producing cells. They used the CRISPR gene-editing tool to correct a defect that caused a form of diabetes, and implanted the cells into mice to reverse diabetes in the animals. Shown is a microscopic image of insulin-secreting beta cells (insulin is green) that were made from stem cells produced from the skin of a patient with Wolfram syndrome [credit: Millman lab Washington University].
Millman and his colleagues had previously discovered how to convert human stem cells into pancreatic beta cells. When such cells encounter blood sugar, they secrete insulin. Recently, these researchers developed a new technique to more efficiently convert human stem cells into beta cells that are considerably better at controlling blood sugar.
In this study, they took the additional steps of deriving these cells from patients and using the CRISPR-Cas9 gene-editing tool on those cells to correct a mutation to the gene that causes Wolfram syndrome (WFS1). Then, the researchers compared the gene-edited cells to insulin-secreting beta cells from the same batch of stem cells that had not undergone editing with CRISPR.
In the test tube and in mice with a severe form of diabetes, the newly grown beta cells that were edited with CRISPR more efficiently secreted insulin in response to glucose. Diabetes disappeared in mice with the CRISPR-edited cells implanted beneath the skin and the animals blood sugar levels remained in normal range for the entire six months they were monitored. Animals receiving unedited beta cells remained diabetic. Although their newly implanted beta cells could produce insulin, it was not enough to reverse their diabetes.
We basically were able to use these cells to cure the problem, making normal beta cells by correcting this mutation, said co-senior investigator Dr Fumihiko Urano, the Samuel E. Schechter Professor of Medicine and a professor of pathology and immunology. Its a proof of concept demonstrating that correcting gene defects that cause or contribute to diabetes in this case, in the Wolfram syndrome gene we can make beta cells that more effectively control blood sugar. Its also possible that by correcting the genetic defects in these cells, we may correct other problems Wolfram syndrome patients experience, such as visual impairment and neurodegeneration.
Were excited about the fact that we were able to combine these two technologies growing beta cells from induced pluripotent stem cells and using CRISPR to correct genetic defects, Millman said. In fact, we found that corrected beta cells were indistinguishable from beta cells made from the stem cells of healthy people without diabetes.
Moving forward, the process of making beta cells from stem cells should get easier, the researchers said. For example, the scientists have developed less intrusive methods, making iPSCs from blood and they are working on developing stem cells from urine samples.
The study is published in Science Translational Medicine.
Read this article:
Induced pluripotent stem cells and CRISPR reversed diabetes in mice - Drug Target Review
Team Reveal Key to the Survival of Dormant Breast Cancer Cells – Technology Networks
By daniellenierenberg
Most breast cancers utilize the female hormone estrogen to grow, so drug-induced estrogen deprivation is used as a treatment in many patients. However, cancer will recur in one-third of these patients. A research team at Dartmouths and Dartmouth-Hitchcocks Norris Cotton Cancer Center, led by Todd W. Miller, PhD, is trying to understand why dormant breast cancer cells survive despite being starved of estrogen. The team discovered that an anti-diabetes drug, metformin, which is being tested in many clinical trials as an anti-cancer agent, actually activated fat metabolism that protected dormant breast cancer cells during estrogen deprivation. The findings suggest that the drug has context-dependent effects on cancer cells. The results, entitled AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells, are newly published online inClinical Cancer Research, a journal of the American Association for Cancer Research.
Knowledge that metformin has context-dependent effects on cancer cells will inform a better understanding of ongoing and prior clinical trials testing metformin, and help shape the design of trials moving forward. Our study indicates that the development of drugs targeting fat metabolism is warranted for breast cancer. Most excitingly, anti-angina drugs that block fat metabolism may be quickly repurposed as potential treatments for cancer and tested in clinical trials, says Miller.
Next steps include clinical trials testing drugs that block fat metabolism in breast cancer. Were also designing preclinical studies to further dissect the roles of fat metabolism in breast and other cancers, with the goal of identifying more refined therapeutic targets that will selectively kill cancer cells and not harm healthy cells, notes Miller.
Reference:Hampsch, et al. (2020) AMPK activation by metformin promotes survival of dormant ER+ breast cancer cells. Clinical Cancer Research DOI: 10.1158/1078-0432.CCR-20-0269.
This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.
Link:
Team Reveal Key to the Survival of Dormant Breast Cancer Cells - Technology Networks
Morning Update: Canadas data gaps are hurting our ability to fight the pandemic – The Globe and Mail
By daniellenierenberg
Good morning,
Crucial data gaps are hurting Canadas ability to fight the COVID-19 pandemic, leaving Canadians in the dark about who is being infected or struggling with the devastated economy.
Canada has a long-standing problem of information gaps, The Globe and Mail found in a year-long series, and that has left us vulnerable during public health crises before. But now, these blind spots could blunt the federal economic rescue effort, hide inequities in deaths from the disease and slow our emergence from self-isolation in the months ahead.
Story continues below advertisement
Father Victor Fernandes puts on personal protection equipment prior to visiting with a patient in the COVID-19 intensive care unit at St. Paul's hospital in downtown Vancouver on April 21, 2020.
JONATHAN HAYWARD/The Canadian Press
This is the daily Morning Update newsletter. If youre reading this on the web, or it was forwarded to you from someone else, you can sign up for Morning Update and more than 20 more Globe newsletters on our newsletter signup page.
Nova Scotia shooting: Premier Stephen McNeil is urging his mourning province to help investigators unravel questions around a gunmans weekend rampage. A new tip line was created specifically for the killings. He acknowledged there is anger over the RCMPs decision not to use the provincial emergency alert system during the 12-hour manhunt, but he asked people to be patient, and wait for answers.
New details are emerging about the chaos that ensued as police tried to capture the killer disguised as an RCMP officer. Audio recordings of first responders communicating on two-way radios provide a glimpse of frantic attempts to help the first victims in the village of Portapique.
A couple pays their respects at a memorial in Portapique, N.S., on April 22, 2020.
Andrew Vaughan/The Canadian Press
Economy: Saskatchewan has laid out a detailed, comprehensive plan to reopen its economy, and is the first province in the country to do so. On May 4, the five phases will begin, opening non-essential medical procedures, and the reopening of provincial parks, campgrounds and golf courses.
In Quebec, Premier Franois Legault is preparing to lay the groundwork next week for a plan to gradually restart the provinces economy and get children back to school.
Rent: Ottawa is proposing to offer commercial rent relief, in the form of loans for landlords of small and medium-sized businesses, that would cover up to 75 per cent of tenants payments for three months, according to sources familiar with the negotiations.
When it comes to investment properties, small landlords across Canada might not qualify for government assistance and are scrambling to figure out how to accommodate rent reductions while making their mortgage payments.
Story continues below advertisement
World news:
Researchers at the University of Oxford are racing to develop a vaccine for COVID-19 and plan to make a million doses of it this summer. The team has been working since January, and clinical trials involving more than 500 volunteers began yesterday. The testing is expected to take several months, but the researchers have already teamed up with manufacturers globally to produce the doses September and millions more by the end of the year. The Globes Paul Waldie reports.
An aerial view of people queuing outside a bank in downtown Quito, Ecuador, on April 22, 2020.
RODRIGO BUENDIA/AFP/Getty Images
Got a news tip that youd like us to look into? E-mail us at tips@globeandmail.com Need to share documents securely? Reach out via SecureDrop
Scheer, Tories refrain from criticizing MP accused of racist comments: People of Asian descent have faced a spike in hate crimes and slurs since the COVID-19 pandemic began in China last year and experts say the comments from an elected official give licence for the attacks to continue.
Child protection organizations seeing significant uptick in predators: In dark-web forums, sexual predators are increasingly discussing the COVID-19 pandemic as an opportunity to exploit children online as they spend more time out of school and on the internet.
Ontarios Serious Fraud Office investigates Bondfield: A special unit of Ontario police officers and prosecutors launched the investigation in 2019, looking into allegations of wrongdoing by a major builder of hospitals, transit stations and other public infrastructure across the province.
Story continues below advertisement
Parents of teen girls killed by Paul Bernardo seek to obtain his file with the parole board: The two families filed for judicial review this month after their requests for the documents under access to information legislation were denied.
MPs seek to overcome hurdle in getting WHO adviser to testify: A parliamentary committee scrutinizing the response to the pandemic is working to get key World Health Organization adviser Bruce Aylward to testify. The WHOs legal counsel has said that Dr. Aylward cannot testify unless he receives authorization from WHO Director-General Tedros Adhanom Ghebreyesus.
World stocks fall on worries over EU stimulus details, coronavirus drug: Global shares fell on Friday, spurred by delays to an agreement on divisive details of the European Unions stimulus package and doubts about progress in the development of drugs to treat COVID-19. In Europe, Britains FTSE 100 was down 0.93 per cent around 6 a.m. ET. Germanys DAX and Frances CAC 40 fell 1.07 per cent and 1.03 per cent, respectively. In Asia, Japans Nikkei fell 0.86 per cent. Hong Kongs Hang Seng fell 0.61 per cent. New York futures were flat. The Canadian dollar was trading at 71.05 U.S. cents.
Canada must protect itself from Americas response to COVID-19
Robyn Urback: It is not implausible that Mr. Trump would retaliate in some sort of petty but potentially grave economic way on supply lines for essential goods, for example if Canada refuses to lift restrictions on non-essential travel if and when the President decides that time is up.
This Ramadan, in solitude, will be more meaningful than ever
Story continues below advertisement
Fatima Al Fahim: But the pandemic need not dampen Ramadan spirits. Physical distancing gives us a reminder of the true meaning of the holy month.
The world has a big China problem now
Campbell Clark: We dont know precisely what happened in China in the early days of COVID-19, but we know some whistle-blowers were stifled and, for whatever reason, officials waited for days to tell the world after learning they faced a serious epidemic.
By Brian Gable
Brian Gable/The Globe and Mail
What you really need is a room edit, not a reno
Especially while in isolation, you may be looking for curatorial guidance, but are keen to avoid the expense of a full interiors overhaul. Some people would rather rip out a wall or buy a bigger house, when all it often takes is reimaging and reworking what you already have, says Joanna Teplin, the Nashville co-founder of the Home Edit. If you want to remodel, read about how you might be able to make the change with what you already have.
Snuppy, right, the first male dog cloned from adult cells by somatic nuclear cell transfer, and the male Afghan hound from which an adult skin cell was taken to clone Snuppy, are seen in this handout photo released in Seoul on Aug. 3, 2005.
Seoul National University via Reuters
Snuppy worlds first cloned dog is born
Story continues below advertisement
If he were born today, Snuppy would be dubbed, in internet lingo, a very good pupper or an excellent doggo. Instead, Snuppy, the first successful clone of a dog, had to settle for merely being hailed as a breakthrough in biotechnology. A team of 45 South Korean researchers, led by stem-cell researcher Hwang Woo-suk, produced the pup using a process called somatic cell nuclear transfer with a cell from the ear of a male Afghan dog, Tai. Snuppy was named for Seoul National University (SNU) and puppy. While other mammals had been cloned successfully starting with Dolly the sheep in 1996 cloning mans best friend proved more challenging. The achievement suggested that, given time and expertise, almost any mammal could be reproduced. Defying concerns that clones would be rife with ailments, Snuppy was generally healthy. He fathered 10 pups by artificial insemination and produced, by stem-cell clone, a litter with three surviving pups. Snuppy died of cancer, a common fate in dogs, just days after his 10th birthday in 2015. Jessie Willms
If youd like to receive this newsletter by e-mail every weekday morning, go here to sign up. If you have any feedback, send us a note.
The rest is here:
Morning Update: Canadas data gaps are hurting our ability to fight the pandemic - The Globe and Mail
AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines – BioSpace
By daniellenierenberg
Findings confirmed that patient-specific autologous dendritic cell vaccines (DCV) induced a different immune response associated with longer survival than autologous tumor cell vaccines (TCV)
IRVINE, Calif.--(BUSINESS WIRE)-- AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today the publication of a paper titled, Cytokine network analysis of immune responses before and after autologous dendritic cell and tumor cell vaccine immunotherapies in a randomized trial, in the Journal of Translational Medicine. Robert O. Dillman, M.D., chief medical officer at AIVITA, and Gabriel I Nistor, M.D., chief scientific officer at AIVITA, authored the article.
The publication provides insight into the innate and adaptive immune responses induced by patient-specific autologous dendritic cell vaccines (DCV) and autologous tumor cell vaccines (TCV), and their impact on survival. DCV was associated with a multipronged innate and adaptive immune response and correlated with improved survival compared to TCV.
In a randomized Phase 2 trial conducted in patients with melanoma, blood samples were obtained at one week before and one week after a course of three weekly injections, which either included dendritic cells loaded ex vivo with antigens from autologous irradiated tumor-initiating cells (DCV), or autologous irradiated tumor-initiating cells alone (TCV). Cytokine network analysis techniques used to analyze the serologic immune responses generated by each immunotherapy confirmed they triggered differing responses. The results help provide insight into a potential underlying immunologic mechanism of action that contributes to improved survival in DCV-treated patients.
This analysis reinforces conclusions from our patient-specific cancer vaccine survival data, which suggested that ex-vivo processing of the same tumor antigens by autologous dendritic cells induces a more advantageous immune response than antigen-only based tumor cell vaccines, said Dr. Nistor. This is reassuring as we continue to further optimize our unique approach in which we use enhanced autologous dendritic cells for targeting each patients own tumor.
AIVITA is currently conducting three independent clinical studies investigating its platform immunotherapy in patients with ovarian cancer, glioblastoma and melanoma. AIVITA uses 100% of proceeds from the sale of its ROOT of SKIN skincare line to support the development of its cancer therapeutic pipeline.
About AIVITAS Clinical Trials
OVARIAN CANCER
AIVITAs ovarian Phase 2 double-blind study is active and enrolling approximately 99 patients who are being randomized in a 2:1 ratio to receive either the autologous tumor-initiating cell-targeting immunotherapy or autologous monocytes as a comparator.
Patients eligible for randomization and treatment will be those (1) who have undergone debulking surgery, (2) for whom a cell line has been established, (3) who have undergone leukapheresis from which sufficient monocytes were obtained, (4) have an ECOG performance grade of 0 or 1 (Karnofsky score of 70-100%), and (5) who have completed primary therapy. The trial is not open to patients with recurrent ovarian cancer.
For additional information about AIVITAs AVOVA-1 trial patients can visit: http://www.clinicaltrials.gov/ct2/show/NCT02033616
GLIOBLASTOMA
AIVITAs glioblastoma Phase 2 single-arm study is active and is enrolling approximately 55 patients to receive the tumor-initiating cell-targeting immunotherapy.
Patients eligible for treatment will be those (1) who have recovered from surgery such that they are about to begin concurrent chemotherapy and radiation therapy (CT/RT), (2) for whom an autologous tumor cell line has been established, (3) have a Karnofsky Performance Status of > 70 and (4) have undergone successful leukapheresis from which peripheral blood mononuclear cells (PBMC) were obtained that can be used to generate dendritic cells (DC). The trial is not open to patients with recurrent glioblastoma.
For additional information about AIVITAs AV-GBM-1 trial please visit: http://www.clinicaltrials.gov/ct2/show/NCT03400917
MELANOMA
AIVITAs melanoma Phase 1B open-label, single-arm study will establish the safety of administering anti-PD1 monoclonal antibodies in combination with AIVITAs tumor-initiating cell-targeting immunotherapy in patients with measurable metastatic melanoma. The study will also track efficacy of the treatment for the estimated 14 to 20 patients. This trial is not yet open for enrollment.
Patients eligible for treatment will be those (1) for whom a cell line has been established, (2) who have undergone leukapheresis from which sufficient monocytes were obtained, (3) have an ECOG performance grade of 0 or 1 (Karnofsky score of 70-100%), (4) who have either never received treatment for metastatic melanoma or were previously treated with enzymatic inhibitors of the BRAF/MEK pathway because of BRAF600E/K mutations and (5) are about to initiate anti-PD1 monotherapy.
For additional information about AIVITAs AV-MEL-1 trial please visit: http://www.clinicaltrials.gov/ct2/show/NCT03743298
About AIVITA Biomedical
AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its therapeutic pipeline and commercial line of skin care products. All proceeds from the sale of AIVITAs skin care products support the treatment of people with cancer.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200423005260/en/
See the original post here:
AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines - BioSpace
Lozier praises promising, and ethical, blindness study – OneNewsNow
By daniellenierenberg
New research results show promise in treating people who are blind.
The National Eye Institute funded the study, which is research considered to be ethical.
Dr. David Prentice of the Charlotte Lozier Institute says there have been discussions over using adult stem cells to restore sight, which he calls a different tack for advancing science and medicine.
It's still an ethical way to go about this, he observes. There's no embryonic stem cells, no fetal tissue, none of this unethical type of research direction.
What the scientists did was turn a skin cell directly into a photoreceptor for vision then transplanted it.
Prenticeadvises the testing is very preliminary after the experiment on mice.
But what they find was when they transplanted this newly formed type of vision cell into the eyes of these blind mice, he says, they restored their vision.
The researchers applied chemicals that transformed one cell type into another needed for vision, and there is now potential to help people with all forms of vision blindness or vision correction, which would include macular degeneration and other retinal disorders.
Editor's note: Original posting attribute comments to wrong person.
View original post here:
Lozier praises promising, and ethical, blindness study - OneNewsNow
How to care for your nails at home now that you can’t go to the salon – AsiaOne
By daniellenierenberg
Just because you cant head to a nail salon right now doesnt mean you should neglect your hands, feet and nails. Plus, the excessive hand washing youve been doing still the most reliable way to protect yourself and your family from Covid-19 can also strip skin of its natural oils and leave it dry. Heres what you can do:
If youre lazy, just use a body scrub in the shower, starting from the feet up. But for a little DIY pampering, start with a foot soak to soften rough heels and soles, then use a foot scrub.
This is important, especially for the hands, as the skin there is thinner than the rest of the body. Its also one of the first places to show signs of ageing. Plus, if the skin on your hands and feet are extremely dry, it could develop micro cracks that allow germs in, making you unwell.
Did you know that massaging cuticle oil on your cuticles and nails every day can improve blood flow to the nail matrix (the root), which makes your nails strong and healthy? If you tend to forget, keep the bottle by your WFH work desk or at your bedside as a nightly reminder.
Here are seven treats to get your hands, feet and nails looking great, when youre stuck at home:
Sweet almond oil and shea butter nourish skin, strengthen nails, and keep your hands soft.
Available atwww.thebodyshop.com/en-sg/and when stores re-open, at The Body Shop.
Not everyone likes using a thick, heavy cream, especially when you dont have the aircon on when you work from home. The heat just makes it all the more sticky.
This lotion is lightweight yet intensively hydrates hands with organic shea butter, USDA-certified organic jojoba seed oil and rice bran oil, yet remains lightweight on the skin.
The latter ingredient contains vitamin E, which protects your hands against UV damagewhich helps give added projection if you work by the window.
Available atwww.thann.com.sg
ALSO READ:9 nail products to help you get a salon-quality manicure at home
A five-oil blend of jojoba, sunflower, argan, pomegranate and tamu moisturise dry cuticles, keeping nails healthy, and soothing skin. We love the rollerball for fuss-free application and the delicate citrus and rose geranium scent.
Available atwww.net-a-porter.com
You wear the mask like socks that reach up to mid-shin, taping the tabs down for a snug fit. The inside of the mask contains its formula of 7 essential oils and 11 herbs (including spearmint, eucalyptus, grapefruit, bergamot, juniper and thyme) to relieve tired feet and legs, and keep them soft and hydrated.
Available atwww.ksisters.sg
For quick exfoliation in the shower, use this creamy body scrub. It contains finely milled pumice stone and bamboo stem to gently buff away dead skin cells and dirt. Skin feels smoother and softer, from top to toe.
Available atwww.aesop.com/sg/andwww.net-a-porter.com
A body lotion is the easiest way to ensure that every bit of skin gets hydration, not just your hands and feet. This one contains nourishing plant oils and butters, together with amino acids, ceramides and antioxidants that lock in moisture, soothe dryness and itch, and protect skin from free radical damage.
Available atwww.sephora.sgand when stores re-open, at Sephora.
An intensive treatment for your hands, the mask contains two layers: The inner layer contains Bulgarian rose, shea butter and rose hip oil to nourish while the outer protective foil creates a warming effect to enhance absorption of the active ingredients. Hands are soft, supple and conditioned in 15 minutes.
Available atwww.sephora.sgand when stores re-open, at Sephora.
For the latest updates on the coronavirus, visithere.
This article was first published in Her World Online.
Read more here:
How to care for your nails at home now that you can't go to the salon - AsiaOne